מושבי לווין

June 3

AstraZeneca | 07:00 - 08:00

Title: TTRansforming Care in Amyloidosis

Click here to view agenda.

  • Hall G

Novo Nordisk | 12:30-14:00

Title: Navigating Residual Risk in Type 2 Diabetes- Innovative Strategies For Improved Outcomes

Click here to view agenda.

  • Hall M

Bayer + AstraZeneca | 12:30-14:00

Title: Heart and Kidney in Harmony: The Game-Changing Potential of SGLT2i & ns-MRA

Click here to view agenda.

  • Hall E

Medison Pharma | 12:30-14:00

Title: Optical Illusion of the PCSK9 Treatment: You Can Get Much More Than What You See

Click here to view agenda.

  • Hall GF

Pfizer Pharmaceuticals Israel | 12:30-14:00

Title: Can We Do BeTTR? Optimizing Diagnosis of Cardiac Amyloidosis in Heart Failure Patients

Click here to view agenda

  • Hall I

Abbott Laboratories | 12:30-14:00

Title: Mitral & TriCuspid interventions – where experience matters

Click here to view Agenda

  • Hall KL

June 4

Novo Nordisk | 12:30-14:00

Title: Mending Broken Hearts with GLP-1 in Obesity Management

Click here to view agenda.

  • Hall E

Boehringer Ingelheim Israel | June 4 | 12:30-14:00

Title: International Latest Updates in Treatment for Heart Failure

Click here to view agenda.

  • Hall GF

Pfizer | June 4 | 12:30-14:00

Title: Navigating Cardiac Amyloidosis: Echocardiography and Differential Diagnosis in Focus

Session is open for medical technicians 

Click here to view agenda.

  • Hall H

Novartis Israel | June 4 | 12:30-14:00

Title: Heart Frontiers: Today’s Lipid Innovations, Tomorrow’s Standards

Click here to view agenda.

  • Hall I

Edwards Lifesciences | June 4 | 12:30-14:00

Title: RESILIA Innovation Session

Click here to view agenda

  • Hall KL

Medtechnica | 12:30-14:00

Title: Expanding Horizons to Improve Outcome- Intra Coronary Imaging

Click here to view agenda

  • Hall M